Well, the lack of consensus on GCR’s efficacy is exactly the thing I’m pointing out. A highly untraceable intervention should not be called “super effective” … I think that risks undermining their credibility. “Potentially a good long-term bet” is very, very different from “super-effective, expert-vetted.”
I was just wondering if there was something I was missing about the proven efficacy of GCR interventions. It sounds like I’m not...in which case, I think it’s a really bad idea for GivingMultiplier to pass those off like they have the proven efficacy of GHD interventions. It feels misleading, and I’m more “EA-friendly” than the average person they’re probably targeting.
And I have no strong view on GCR interventions. Seems like they’d be hard to prove traceability/impact, but I haven’t spend much time thinking about it.
I think there’s multiple approaches they could take:
Describe all charities as “super-effective”, a term that has presumably been tested directly and/or indirectly to maximize marketability
Use some other term that applies precisely to all charities but is less effective at drawing donations
Make a distinction between (e.g.) GiveWell and GCR work
Not include GCR in their portfolio
I can see an argument for 4 (i.e. start new donors with more straightforward work). Also, if GCR work is too speculative to justify pursuing, then 4 is clearly the best option.
However, if you believe that GCR work is sufficiently well-justified (as Giving Multiplier seems to), I do think 1 > 2 and 3.
2 and 3 decrease the effectiveness of the organization for the sake of precision. Their FAQ on the home page addresses how they defer to other actors, who make decisions based on the best available evidence. Anyone unsatisfied by that answer has links to Founders Pledge and can learn more about their methodology there.
Super-effective is a marketing label, not a scientific one. They define it reasonably, and I don’t think it would come across as dishonest or misleading to someone without EA context.
Fair enough. I have no doubt that they picked the term for marketing purposes. But I’m sure you’re right that they would defend it as “highest EV,” as opposed to “rigorously studied causal chain.”
Well, the lack of consensus on GCR’s efficacy is exactly the thing I’m pointing out. A highly untraceable intervention should not be called “super effective” … I think that risks undermining their credibility. “Potentially a good long-term bet” is very, very different from “super-effective, expert-vetted.”
I was just wondering if there was something I was missing about the proven efficacy of GCR interventions. It sounds like I’m not...in which case, I think it’s a really bad idea for GivingMultiplier to pass those off like they have the proven efficacy of GHD interventions. It feels misleading, and I’m more “EA-friendly” than the average person they’re probably targeting.
And I have no strong view on GCR interventions. Seems like they’d be hard to prove traceability/impact, but I haven’t spend much time thinking about it.
I think there’s multiple approaches they could take:
Describe all charities as “super-effective”, a term that has presumably been tested directly and/or indirectly to maximize marketability
Use some other term that applies precisely to all charities but is less effective at drawing donations
Make a distinction between (e.g.) GiveWell and GCR work
Not include GCR in their portfolio
I can see an argument for 4 (i.e. start new donors with more straightforward work). Also, if GCR work is too speculative to justify pursuing, then 4 is clearly the best option.
However, if you believe that GCR work is sufficiently well-justified (as Giving Multiplier seems to), I do think 1 > 2 and 3.
2 and 3 decrease the effectiveness of the organization for the sake of precision. Their FAQ on the home page addresses how they defer to other actors, who make decisions based on the best available evidence. Anyone unsatisfied by that answer has links to Founders Pledge and can learn more about their methodology there.
Super-effective is a marketing label, not a scientific one. They define it reasonably, and I don’t think it would come across as dishonest or misleading to someone without EA context.
Fair enough. I have no doubt that they picked the term for marketing purposes. But I’m sure you’re right that they would defend it as “highest EV,” as opposed to “rigorously studied causal chain.”